| | |
Page
|
| |||
| | | | S-ii | | | |
| | | | S-iii | | | |
| | | | S-1 | | | |
| | | | S-8 | | | |
| | | | S-9 | | | |
| | | | S-10 | | | |
| | | | S-11 | | | |
| | | | S-13 | | | |
| | | | S-15 | | | |
| | | | S-19 | | | |
| | | | S-26 | | | |
| | | | S-26 | | | |
| | | | S-26 | | | |
| | | | S-26 | | |
| | |
As of September 30, 2020
|
| |||||||||||||||
| | |
Actual
|
| |
Pro Forma
|
| |
Pro Forma
As Adjusted |
| |||||||||
| | |
(in thousands, except share and per share data)
|
| |||||||||||||||
Cash and cash equivalents
|
| | | $ | 70,642 | | | | | $ | 146,042 | | | | | $ | | | |
Long-term debt, net of discount, including current portion
|
| | | $ | 48,972 | | | | | $ | 48,972 | | | | | $ | | | |
Stockholders’ equity: | | | | | | | | | | | | | | | | | | | |
Common stock, $0.0001 par value; 100,000,000 shares
authorized, actual, pro forma, and pro forma as adjusted; 63,070,980 shares issued and outstanding, actual; 71,327,980 shares issued and outstanding, pro forma; shares issued and outstanding, pro forma as adjusted |
| | | | 6 | | | | | | 7 | | | | | | | | |
Additional paid-in capital
|
| | | | 449,507 | | | | | | 524,906 | | | | | | | | |
Accumulated deficit
|
| | | | (453,639) | | | | | | (453,639) | | | | | | | | |
Total stockholders’ deficit
|
| | | | (4,126) | | | | | | 71,274 | | | | | | | | |
Total capitalization
|
| | | $ | 44,846 | | | | | $ | 120,246 | | | | | $ | | | |
|
|
Public offering price per share
|
| | | | | | | | | $ | | | |
|
Historical net tangible book value per share as of September 30, 2020
|
| | | $ | (0.07) | | | | |||||
|
Increase in net tangible book value per share attributable to pro forma adjustments described above
|
| | | | 1.07 | | | | |||||
|
Pro forma net tangible book value per share as of September 30, 2020
|
| | | | 1.00 | | | | |||||
|
Increase in pro forma net tangible book value per share attributable to new investors purchasing common stock in this offering
|
| | | | | | | | |||||
|
Pro forma as adjusted net tangible book value per share after this offering
|
| | | | | | | | | | | | |
|
Dilution per share to new investors purchasing common stock in this offering
|
| | | | | | | | | $ | | | |
|
Underwriter
|
| |
Number of
Shares |
|
Jefferies LLC
|
| |
|
|
Piper Sandler & Co.
|
| | | |
Total
|
| | | |
|
| | |
Per Share
|
| |
Total
|
| ||||||||||||||||||
| | |
Without
Option to Purchase Additional Shares |
| |
With
Option to Purchase Additional Shares |
| |
Without
Option to Purchase Additional Shares |
| |
With
Option to Purchase Additional Shares |
| ||||||||||||
Public offering price
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | ||||
Underwriting discounts and commissions paid by us
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | ||||
Proceeds to us, before expenses
|
| | | $ | | | | | $ | | | | | $ | | | | | $ | | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 4 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 18 | | | |
| | | | | 22 | | | |
| | | | | 25 | | | |
| | | | | 26 | | | |
| | | | | 27 | | | |
| | | | | 29 | | | |
| | | | | 31 | | | |
| | | | | 31 | | |